Middle East Pharmaceutical Industries Company (TADAWUL:4016)

Saudi Arabia · Delayed Price · Currency is SAR

66.85

+0.15 (0.22%)

Sep 3, 2026, 3:10 PM AST

Revenue by Segment

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Private Customers	310.04M	268.29M	245.32M	207.97M	-
Public Customers	93.43M	75.68M	55.91M	68.58M	-
Export Customers	57.02M	50.03M	37.22M	26.11M	-
Medicines	-	-	-	-	157.70M
Cosmetics	-	-	-	-	129.52M
Total	460.48M	394.00M	338.44M	302.66M	287.22M

Revenue by Geography

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Kingdom of Saudi Arabia	403.46M	343.97M	301.22M	276.55M	259.78M
United Arab Emirates	12.38M	18.06M	12.93M	-	-
Kuwait	13.66M	10.94M	9.35M	-	-
Iraq	9.00M	4.39M	-	-	-
Oman	2.43M	1.56M	-	-	-
Yemen	3.81M	3.89M	-	-	-
Other Export	4.85M	2.47M	-	26.11M	27.44M
Bahrain	2.83M	2.66M	-	-	-
Jordan	2.49M	2.65M	-	-	-
Libya	5.57M	3.41M	-	-	-
Other Countries	-	-	14.94M	-	-
Total	460.48M	394.00M	338.44M	302.66M	287.22M